127 related articles for article (PubMed ID: 7634411)
1. Identification of 3 alpha-hydroxy-cyproterone acetate as a metabolite of cyproterone acetate in the bile of female rats and the potential of this and other already known or putative metabolites to form DNA adducts in vitro.
Kerdar RS; Baumann A; Brudny-Klöppel M; Biere H; Blode H; Kuhnz W
Carcinogenesis; 1995 Aug; 16(8):1835-41. PubMed ID: 7634411
[TBL] [Abstract][Full Text] [Related]
2. Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures.
Topinka J; Andrae U; Schwarz LR; Wolff T
Carcinogenesis; 1993 Mar; 14(3):423-7. PubMed ID: 8453718
[TBL] [Abstract][Full Text] [Related]
3. Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver.
Werner S; Topinka J; Wolff T; Schwarz LR
Carcinogenesis; 1995 Oct; 16(10):2369-72. PubMed ID: 7586137
[TBL] [Abstract][Full Text] [Related]
4. Cyproterone acetate is an integral part of hepatic DNA adducts induced by this steroidal drug.
Topinka J; Binkova B; Schwarz LR; Wolff T
Carcinogenesis; 1996 Jan; 17(1):167-9. PubMed ID: 8565129
[TBL] [Abstract][Full Text] [Related]
5. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes.
Werner S; Kunz S; Beckurts T; Heidecke CD; Wolff T; Schwarz LR
Mutat Res; 1997 Dec; 395(2-3):179-87. PubMed ID: 9465929
[TBL] [Abstract][Full Text] [Related]
6. Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation.
Werner S; Kunz S; Wolff T; Schwarz LR
Cancer Res; 1996 Oct; 56(19):4391-7. PubMed ID: 8813132
[TBL] [Abstract][Full Text] [Related]
7. DNA-damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver.
Topinka J; Binkova B; Zhu HK; Andrae U; Neumann I; Schwarz LR; Werner S; Wolff T
Carcinogenesis; 1995 Jul; 16(7):1483-7. PubMed ID: 7542174
[TBL] [Abstract][Full Text] [Related]
8. Use of rat and human liver slices for the detection of steroid hormone-induced DNA-adducts in vitro by means of the (32)P-postlabeling technique.
Baumann A; Kerdar RS; Cramer P; Feser W; Blode H; Salomon A; Kuhnz W
Pharmacol Toxicol; 1996 Apr; 78(4):214-23. PubMed ID: 8861778
[TBL] [Abstract][Full Text] [Related]
9. Time-related induction of DNA repair synthesis in rat hepatocytes following in vivo treatment with cyproterone acetate.
Kasper P; Mueller L
Carcinogenesis; 1996 Oct; 17(10):2271-4. PubMed ID: 8895500
[TBL] [Abstract][Full Text] [Related]
10. The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue transgenic F344 rats.
Krebs O; Schäfer B; Wolff T; Oesterle D; Deml E; Sund M; Favor J
Carcinogenesis; 1998 Feb; 19(2):241-5. PubMed ID: 9498271
[TBL] [Abstract][Full Text] [Related]
11. Formation of DNA-adducts by selected sex steroids in rat liver.
Feser W; Kerdar RS; Blode H; Reimann R
Hum Exp Toxicol; 1996 Jul; 15(7):556-62. PubMed ID: 8818708
[TBL] [Abstract][Full Text] [Related]
12. Cyproterone acetate: is it hepato- or genotoxic?
Rabe T; Feldmann K; Heinemann L; Runnebaum B
Drug Saf; 1996 Jan; 14(1):25-38. PubMed ID: 8713486
[TBL] [Abstract][Full Text] [Related]
13. In vitro mutagenicity studies on cyproterone acetate using female rat hepatocytes for metabolic activation and as indicator cells.
Kasper P; Tegethoff K; Mueller L
Carcinogenesis; 1995 Oct; 16(10):2309-14. PubMed ID: 7586127
[TBL] [Abstract][Full Text] [Related]
14. Studies on the formation of hepatic DNA adducts by the antiandrogenic and gestagenic drug, cyproterone acetate: 1. adduct levels in various species including man and 2. persistence and accumulation in the rat.
Werner S; Topinka J; Kunz S; Beckurts T; Heidecke CD; Schwarz LR; Wolff T
Adv Exp Med Biol; 1996; 387():253-7. PubMed ID: 8794219
[No Abstract] [Full Text] [Related]
15. Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in gamma-glutamyltranspeptidase-positive cells.
Neumann I; Thierau D; Andrae U; Greim H; Schwarz LR
Carcinogenesis; 1992 Mar; 13(3):373-8. PubMed ID: 1347714
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and 32p-postlabeling analysis of DNA adducts derived from the environmental contaminant 3-nitrobenzanthrone.
Osborne MR; Arlt VM; Kliem C; Hull WE; Mirza A; Bieler CA; Schmeiser HH; Phillips DH
Chem Res Toxicol; 2005 Jun; 18(6):1056-70. PubMed ID: 15962941
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific induction of apoptosis by cyproterone acetate in primary rat hepatocytes.
Kasper P; Mueller L
Carcinogenesis; 1999 Nov; 20(11):2185-8. PubMed ID: 10545424
[TBL] [Abstract][Full Text] [Related]
18. Identification of the major hepatic DNA adduct formed by the food mutagen 2-amino-9H-pyrido[2,3-b]indole (A alpha C).
Pfau W; Schulze C; Shirai T; Hasegawa R; Brockstedt U
Chem Res Toxicol; 1997 Oct; 10(10):1192-7. PubMed ID: 9348443
[TBL] [Abstract][Full Text] [Related]
19. No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part II. Multiple dose treatment.
Topinka J; Oesterle D; Reimann R; Wolff T
Mutat Res; 2004 Jun; 550(1-2):101-8. PubMed ID: 15135644
[TBL] [Abstract][Full Text] [Related]
20. Formation of DNA adducts by the food mutagen 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline (4,8-DiMeIQx) in vitro and in vivo. Identification of a N2-(2'-deoxyguanosin-8-yl)-4,8-DiMeIQx adduct.
Frandsen H; Grivas S; Turesky RJ; Andersson R; Dragsted LO; Larsen JC
Carcinogenesis; 1994 Nov; 15(11):2553-8. PubMed ID: 7955105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
